PUBLICATIONS

Mayo Clinic Proceedings

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

  • dc-oped-thumb.png
    Op-Ed: Vaccine race creates blind spots
    View at The Hill
  • zuma-ash-thumb.png
    ZUMA-19 Abstract Accepted for Presentation at ASH 2020 Annual Meeting
    View Abstract
  • mayo proceedings_thumb.png
    Mayo Clinic Proceedings Lenzilumab COVID-19 Case-Control Study
    View Manuscript
  • biorxiv.png
    GM-CSF and Cytokine Storm in Coronavirus
    View at bioRxiv
  • waller_thumb.png
    A new role for an old cytokine: GM-CSF amplifies GVHD
    View Full Text
  • F1.large.jpg
    Role of GM-CSF in acute GVHD
    View at ashpublications.org
  • stm_thumb.png
    Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF–licensed myeloid cells
    View/Download
  • blood.png
    Lenzilumab Study Published in ‘blood’
    View at ashpublications.org
  • gmcsf.png
    Humanigen GM-CSF Review
    View/Download
  • ash_thumb.png
    Lenzilumab at ASH 2018 - Abstract
    View at ashpublications.org
  • vail_thumb.png
    Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
    View/Download
  • cancers_thumb.png
    EphA3 Publication in 'Cancers'
    View/Download
  • plos_thumb.png
    Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth
    View/Download
  • emr1.png
    Eosinophil surface receptor EMR1: a novel therapeutic target for eosinophilic disorders
    View/Download

CAR-T–cell neurotoxicity: hope is on the horizon

Editorial in Blood Journal

by Omar Ahmed

©2020 Humanigen, Inc.  All rights reserved